All In Biotech

Free tool

FAERS Monitor: Arikayce Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207356 or its brand name (Arikayce Kit, Amikacin Sulfate). Reports on generic versions are filed under their own applications.

Reports

17,297

Serious

14,295

83% of reports

Hospitalization

7,341

Death reported

3,446

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use2,052
  • drug ineffective1,836
  • cough1,733
  • dyspnoea1,666
  • therapy interrupted1,437
  • hospitalisation1,415
  • death1,154
  • dysphonia1,046
  • nausea800
  • product dose omission issue786
  • fatigue781
  • pneumonia703
  • diarrhoea691
  • pyrexia662
  • condition aggravated654

Reports by year received

View as table
YearReports
2004137
2005104
200698
2007134
2008136
2009120
2010146
2011230
2012212
2013220
2014209
2015275
2016408
2017508
2018811
20192,136
20201,812
20211,453
20221,387
20231,869
20242,088
20251,781
20261,023

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,862 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
therapy interruptedSignal1,43724.923.732,433
dysphoniaSignal1,04622.120.820,756
hospitalisationSignal1,41511.310.713,239
coughSignal1,7337.67.29,921
dyspnoeaSignal1,6663.63.43,181
product dose omission issueSignal7863.33.01,241
off label useSignal2,0522.92.72,571
pneumoniaSignal7032.62.5727
condition aggravatedSignal6542.62.4661
pyrexiaSignal6622.32.2508
drug ineffective1,8361.71.6557
death1,1541.61.5292
diarrhoea6911.31.250
nausea8001.21.135
fatigue7811.21.132

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.